FDA-NIH 2024 | D1S03 - A Reflection on Today’s Seminar’s Title

26 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
This presentation discussed a rundown of the Do’s and Don’ts from FDA’s Oncology Center of Excellence (OCE).

Timestamps

01:37 – Do’s and Don’ts

04:37 – The One Imperative Action

05:32 – How to Accomplish That Task

08:20 – Engage

09:48 – Summary

Speaker:

Jeff Summers, MD
Associate Office Director
Office of Oncologic Diseases (OOD)
Office of New Drugs (OND | CDER

Learn more at: https://www.fda.gov/drugs/news-events-human-drugs/fda-nih-regulatory-dos-and-donts-tips-fda-09042024

-----------------------

FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.

Upcoming Training - https://www.fda.gov/cdersbia
SBIA Listserv - https://public.govdelivery.com/accounts/USFDA/subscriber/new?topic_id=USFDA_352
SBIA 2024 Playlist - https://www.youtube.com/playlist?list=PLey4Qe-Uxcxaf1HvpvnKO8-n8u9QW412g
SBIA 2025 Playlist - https://www.youtube.com/playlist?list=PLey4Qe-Uxcxa5NzgN2UeQcHqklugEvBje
SBIA LinkedIn - https://www.linkedin.com/showcase/cder-small-business-and-industry-assistance
SBIA Training Resources - https://www.fda.gov/cdersbialearn
Twitter - https://twitter.com/FDA_Drug_Info
Email - [email protected]
Phone - (301) 796-6707 I (866) 405-5367
Categoria
Oncology
Commenta per primo questo video.

Prossimo